Quixin
New Eye Test May Help Predict Risk of Glaucoma »
"Jan. 4, 2013 -- A new study from Australia may offer a new way of identifying people at risk of glaucoma years before vision loss happens.
Glaucoma is a leading cause of blindness. But because vision damage often occurs gradually, mos"...
Read the New Eye Test May Help Predict Risk of Glaucoma article »
Quixin
INDICATIONS
QUIXIN® (levofloxacin ophthalmic solution 0.5%) solution is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms:
| AEROBIC GRAM-POSITIVE MICROORGANISMS | AEROBIC GRAM-NEGATIVE MICROORGANISMS |
| Corynebacterium species* | Acinetobacter Iwoffii* |
| Staphylococcus aureus | Haemophilus influenzae |
| Staphylococcus epidermidis | Serratia marcescens* |
| Streptococcus pneumoniae | |
| Streptococcus (Groups C/F) | |
| Streptococcus (Group G) | |
| Viridans group streptococci | |
| *Efficacy for this organism was studied in fewer than 10 infections. | |
DOSAGE AND ADMINISTRATION
Days 1 and 2
Instill one to two drops in the affected eye(s) every 2 hours while awake, up to 8 times per day.
Days 3 through 7
Instill one to two drops in the affected eye(s) every 4 hours while awake, up to 4 times per day.
HOW SUPPLIED
QUIXIN® (levofloxacin ophthalmic solution) 0.5% is supplied in a white, low density polyethylene bottle with a controlled dropper tip and a tan, high density polyethylene cap in the following size: 5 mL fill in 5 cc container - NDC 68669-135-05
Storage
Store at 15° – 25°C (59° – 77°F).
Manufactured by: Santen Oy, P. O. Box 33, FIN-33721 Tampere, Finland. Licensed from: Daiichi Sankyo Co., Ltd., Tokyo, Japan. Marketed by: VISTAKON® Pharmaceuticals, LLC Jacksonville, FL 32256 USA. April 2006 Version. FDA revision date: 4/11/2005
Last reviewed on RxList: 12/18/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Quixin Information
Quixin - User Reviews
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
WebMD Daily
Get breaking medical news.






